None of the Covid vaccines originally approved for emergency use completed trial results. Supreme Court should therefore ask ...

Vaccine scepticism suddenly had a much larger audience, bringing together people across swathes of the political spectrum.

Former prime minister late Manmohan Singh's role in the 1991 economic reforms marked a turning point for India’s ...

Gen AI and other technologies are set to transform the healthcare realm. The collaboration between engineers, clinicians, and ...

How the Pune-based Serum Institute of India churned out the Covishield vaccine in hundreds of million dosages, or how Bharat Biotech struggled to churn out the India-made Covaxin vaccine.

READ ALSO: Covishield under scanner: Is Covaxin safe? Standing for prolonged periods without breaks can also lead to its own set of health issues, including fatigue, muscle strain, and joint pain.

After the L&T CEO’s remark on the 90-hour work week created a storm, several industrialists, including Anand Mahindra and Adar Poonawalla, expressed their reservations.

Reviews worldwide are being done by various committees, including India’s National AEFI committee. For now, the government says both Covishield and Covaxin are safe and all those in the priority ...

It markets the Oxford–AstraZeneca COVID-19 vaccine under the brand name Covishield in India. The company collaborates with international health organizations like WHO and PATH to enhance vaccine ...

Find 2 Crore Offer Latest News, Videos & Pictures on 2 Crore Offer and see latest updates, news, information from NDTV.COM. Explore more on 2 Crore Offer.

Pune: While speaking on 67 cases of Guillain-Barre Syndrome (GBS) reported in Pune district, Assistant Health Officer, Pune Municipal Corporation Vaishali Jadhav said that a total of 67 cases of ...